Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2024. Start Trial.
Date Value
October 28, 2026 26.18
October 27, 2026 25.53
October 26, 2026 25.41
October 23, 2026 25.87
October 22, 2026 26.97
October 21, 2026 28.35
October 20, 2026 31.55
October 19, 2026 30.36
October 16, 2026 30.22
October 15, 2026 29.88
October 14, 2026 30.11
October 13, 2026 30.87
October 12, 2026 31.92
October 09, 2026 31.69
October 08, 2026 31.12
October 07, 2026 31.44
October 06, 2026 30.47
October 05, 2026 30.76
October 02, 2026 29.82
October 01, 2026 30.30
September 30, 2026 31.01
September 29, 2026 32.06
September 28, 2026 32.85
September 25, 2026 32.37
September 24, 2026 31.97
Date Value
September 23, 2026 31.86
September 22, 2026 33.78
September 21, 2026 31.97
September 18, 2026 35.59
September 17, 2026 35.35
September 16, 2026 33.44
September 15, 2026 36.27
September 14, 2026 33.30
September 11, 2026 31.92
September 10, 2026 33.64
September 09, 2026 34.88
September 08, 2026 33.87
September 04, 2026 33.75
September 03, 2026 33.19
September 02, 2026 32.37
September 01, 2026 30.67
August 31, 2026 31.35
August 28, 2026 31.92
August 27, 2026 32.16
August 26, 2026 31.46
August 25, 2026 33.05
August 24, 2026 33.02
August 21, 2026 32.03
August 20, 2026 35.11
August 19, 2026 34.26

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Mesoblast Ltd. 2.290
Immutep Ltd. --
CSL Ltd. --
Ceryvyn Therapeutics Ltd. --
Propanc Biopharma, Inc. 0.743

Price to Book Value Related Metrics

PE Ratio 99.04
PS Ratio 3.606
Price 9.26
Earnings Yield 1.01%
Market Cap 3.146B
Normalized PE Ratio 169.60